Getein Biotech, Inc (SHA:603387)
China flag China · Delayed Price · Currency is CNY
9.09
-0.25 (-2.68%)
May 21, 2026, 3:00 PM CST

Getein Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,6104,2454,1845,5796,3397,254
Market Cap Growth
14.63%1.46%-25.00%-12.00%-12.61%-18.60%
Enterprise Value
3,9723,8463,8965,5725,4546,496
Last Close Price
9.098.378.0710.5011.5613.02
PE Ratio
20.6619.2418.7119.9412.7118.18
Forward PE
-17.4317.4317.4317.4317.43
PS Ratio
4.294.043.594.083.485.18
PB Ratio
1.571.491.542.042.383.19
P/TBV Ratio
1.741.651.692.312.703.62
P/FCF Ratio
16.3917.5415.6974.2923.8828.70
P/OCF Ratio
11.0710.819.8916.7413.1316.78
EV/Sales Ratio
3.783.663.344.072.994.64
EV/EBITDA Ratio
13.5711.2912.7118.729.7114.21
EV/EBIT Ratio
19.0214.9717.6526.2510.9715.86
EV/FCF Ratio
14.1215.8914.6174.2020.5425.70
Debt / Equity Ratio
0.140.170.210.240.220.22
Debt / EBITDA Ratio
1.111.381.862.181.041.08
Debt / FCF Ratio
1.431.992.188.882.231.96
Net Debt / Equity Ratio
-0.33-0.26-0.15-0.10-0.21-0.48
Net Debt / EBITDA Ratio
-2.71-2.19-1.37-0.90-1.01-2.37
Net Debt / FCF Ratio
-3.40-3.08-1.57-3.59-2.13-4.29
Asset Turnover
0.290.280.310.370.540.48
Inventory Turnover
1.721.681.771.922.582.09
Quick Ratio
2.371.891.501.561.772.54
Current Ratio
3.212.691.982.202.502.91
Return on Equity (ROE)
7.81%7.60%8.42%10.51%20.41%19.26%
Return on Assets (ROA)
4.55%4.30%3.69%3.56%9.11%8.77%
Return on Invested Capital (ROIC)
12.21%10.83%8.39%8.65%27.21%34.26%
Return on Capital Employed (ROCE)
9.10%8.90%8.00%7.60%18.30%17.60%
Earnings Yield
5.05%5.20%5.34%5.01%7.87%5.50%
FCF Yield
6.10%5.70%6.37%1.35%4.19%3.48%
Dividend Yield
1.93%-2.23%1.91%2.94%1.86%
Payout Ratio
44.45%46.78%49.63%78.42%28.21%25.96%
Buyback Yield / Dilution
0.09%1.33%0.08%0.08%0.48%-0.72%
Total Shareholder Return
2.01%1.33%2.31%1.99%3.42%1.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.